Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
uninsubria.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
☰
Pubblicazioni
BLOOD ADVANCES
Rivista
Codice:
E238919
ISSN:
2473-9537
Dati Generali
Dati Generali
Pubblicazioni (21)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
Articolo
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
Articolo
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
Articolo
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Articolo
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
Articolo
American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients
Articolo
American society of hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism
Articolo
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
Articolo
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML
Articolo
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
Articolo
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
Articolo
DOACs vs LMWHs in hospitalized medical patients: A systematic review and meta-analysis that informed 2018 ASH guidelines
Articolo
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?
Articolo
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Articolo
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study
Articolo
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Articolo
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
Articolo
Risk-assessment models for VTE and bleeding in hospitalized medical patients: An overview of systematic reviews
Articolo
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.
Articolo
Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients
Articolo
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
